Markers of prognosis specific to influenza infection: Are we there yet?

American Journal of Respiratory and Critical Care Medicine

Volumn 189, Issue 10, 2014, Pages 1159-1160

  Radigan, Kathryn A ^a   Mutlu, Gökhan M ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; OSELTAMIVIR;

2009 H1N1 INFLUENZA; ADULT RESPIRATORY DISTRESS SYNDROME; AGE DISTRIBUTION; ANTIBODY TITER; ANTIGEN ANTIBODY COMPLEX; ANTIVIRAL THERAPY; ARTIFICIAL VENTILATION; CRITICALLY ILL PATIENT; DISEASE MARKER; DISEASE SEVERITY; EDITORIAL; HOSPITALIZATION; HUMAN; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; INFLUENZA; INFLUENZA VACCINATION; INTENSIVE CARE UNIT; MORBIDITY; MORTALITY; NONHUMAN; PANDEMIC; PRIORITY JOURNAL; PROGNOSIS; UNITED STATES;

EID: 84901045168     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201403-0556ED     Document Type: Editorial

References (19)

1. Jhung MA, Swerdlow D, Olsen SJ, Jernigan D, Biggerstaff M, Kamimoto L, Kniss K, Reed C, Fry A, Brammer L, et al. Epidemiology of 2009 pandemic influenza A (H1N1) in the United States. Clin Infect Dis 2011;52:S13-S26.
2. CDC. CDC estimates of 2009 H1N1 influenza cases, hospitalizations and deaths in the United States, April 2009-March 13, 2010. 2010 Apr 19 [accessed 2014 Mar 27]. Available from: http://www.cdc.gov/h1n1flu/estimates/April-March- 13.htm
3. Viboud C, Miller M, Olson D, Osterholm M, Simonsen L. Preliminary estimates of mortality and years of life lost associated with the 2009 A/H1N1 pandemic in the us and comparison with past influenza seasons. PLoS Curr 2010;2:RRN1153.
4. Mullooly JP, Bridges CB, Thompson WW, Chen J, Weintraub E, Jackson LA, Black S, Shay DK; Vaccine Safety Datalink Adult Working Group. Influenza-and RSV-associated hospitalizations among adults. Vaccine 2007;25:846-855.
5. Centers for Disease Control and Prevention (CDC). Estimates of deaths associated with seasonal influenza-United States, 1976-2007. MMWR Morb Mortal Wkly Rep 2010;59:1057-1062.
6. Bautista E, Chotpitayasunondh T, Gao Z, Harper SA, Shaw M, Uyeki TM, Zaki SR, Hayden FG, Hui DS, Kettner JD, et al.; Writing Committee of the WHO Consultation on Clinical Aspects of Pandemic (H1N1) 2009 Influenza. Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N Engl JMed 2010;362:1708-1719.
7. Cox CM, D'Mello T, Perez A, Reingold A, Gershman K, Yousey-Hindes K, Arnold KE, Farley MM, Ryan P, Lynfield R, et al.; Emerging Infections Programs Network. Increase in rates of hospitalization due to laboratory-confirmed influenza among children and adults during the 2009-10 influenza pandemic. J Infect Dis 2012;206: 1350-1358.
8. Hancock K, Veguilla V, Lu X, Zhong W, Butler EN, Sun H, Liu F, Dong L, DeVos JR, Gargiullo PM, et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 2009;361: 1945-1952.
9. Centers for Disease Control and Prevention (CDC). Swine influenza A (H1N1) infection in two children-Southern California, March-April 2009. MMWR Morb Mortal Wkly Rep 2009;58:400-402.
10. Guihot A, Luyt C-E, Parrot A, Rousset D, Cavaillon J-M, Boutolleau D, Fitting C, Pajanirassa P, Mallet A, Fartoukh M, et al; FluBAL Study Group. Low titers of serum antibodies inhibiting hemagglutination predict fatal fulminant influenza A(H1N1) 2009 infection. Am J Respir Crit Care Med 2014;189:1240-1249.
11. Li G, Yilmaz M, Kojicic M, Fernández-Pérez E, Wahab R, Huskins WC, Afessa B, Truwit JD, Gajic O. Outcome of critically ill patients with influenza virus infection. J Clin Virol 2009;46:275-278.
12. Hak E, Wei F, Nordin J, Mullooly J, Poblete S, Nichol KL. Development and validation of a clinical prediction rule for hospitalization due to pneumonia or influenza or death during influenza epidemics among community-dwelling elderly persons. J Infect Dis 2004;189:450-458.
13. Menon DK, Taylor BL, Ridley SA; Intensive Care Society, UK. Modelling the impact of an influenza pandemic on critical care services in England. Anaesthesia 2005;60:952-954.
14. Catania J, Que LG, Govert JA, Hollingsworth JW, Wolfe CR. High intensive care unit admission rate for 2013-2014 influenza is associated with a low rate of vaccination. Am J Respir Crit Care Med 2014;189:485-487.
15. Centers for Disease Control and Prevention (CDC). Estimated influenza illnesses and hospitalizations averted by influenza vaccination-United States, 2012-13 influenza season. MMWR Morb Mortal Wkly Rep 2013;62:997-1000.
16. Castilla J, Godoy P, Doḿinguez A, Mart́inez-Baz I, Astray J, Mart́in V, Delgado-Rodŕiguez M, Baricot M, Soldevila N, Mayoral JM, et al.; CIBERESP Cases and Controls in Influenza Working Group Spain. Influenza vaccine effectiveness in preventing outpatient, inpatient, and severe cases of laboratory-confirmed influenza. Clin Infect Dis 2013;57:167-175.
17. Muthuri SG, Venkatesan S, Myles PR, Leonardi-Bee J, Al Khuwaitir TSA, Al Mamun A, Anovadiya AP, Azziz-Baumgartner E, Bá ez C, Bassetti M, et al.; PRIDE Consortium Investigators. Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza a H1N1pdm09 virus infection: a meta-analysis of individual participant data. Lancet Respir Med [online ahead of print] 19 Mar 2014; DOI:10.1016/S2213-2600(14)70041-4.
18. Freemantle N, Shallcross LJ, Kyte D, Rader T, Calvert MJ. Oseltamivir: the real world data. BMJ 2014;348:g2371.
19. Charlson ME, Horwitz RI. Applying results of randomised trials to clinical practice: impact of losses before randomisation. Br Med J (Clin Res Ed) 1984;289:1281-1284.